Frank Pallone

This rule would have zero impact on the actual price of prescription drugs

The 340B program is not the problem or the solution to rising drug prices

Twenty-five years ago, Congress passed bipartisan legislation establishing the 340B program. Since its inception, the 340B program has played a critical role in ensuring that low-income and vulnerable individuals have access to affordable…

Today, under current law, medical product manufacturers are required to demonstrate the safety and effectiveness of each intended use of their medical product.

This review process has been critical to protecting and promoting public health by ensuring that the benefits of medical products that are prescribed to patients outweigh the risk.

I hope that our discussion today will help to inform whether or not it would be appropriate for this committee to take further action.

I greatly appreciate his willingness to continue to address concerns he has heard about the legislative language.

I believe Morgan Griffith's bill, H.R. 1703, is a serious, well-thought-out policy proposal that responsibly sets the rules of the road in a constitutionally sound manner.

I am willing to have that discussion. However, broadening communication in the way it is proposed... would, in my opinion, undermine FDA's regulatory review process.

Would you agree that deep cuts to addiction services that might result from the Senate TrumpCare bill, for example, that if states decided because of the cuts in the Senate TrumpCare bill, that those kinds of cuts to addiction treatment…

Obviously, my concern is that, in states most heavily impacted by the opioid epidemic, if you have cuts to Medicaid that that may lead to cuts in addiction treatment and exacerbate the process.

To the contrary, though, I think Medicaid has provided for a great deal of innovation in how states have responded to the opioid crisis.

I fear that if Republicans are successful in passing TrumpCare, we will end up going in the opposite direction when it comes to fighting the drug problem that has so devastated our communities.

We must invest in our healthcare system and its critical public programs for the long term, and Medicaid is clearly a critical pillar that should be strengthened, not decimated.

No cosmetic changes can effectively offset the damage that could be caused by repealing the ACA and cutting hundreds of billions of dollars from the Medicaid program.

These cuts could not come at a worse time from the perspective of the opioids crisis for states and for people who depend on the coverage Medicaid provides.

Yet, Republicans persist in their attempts to gut the Medicaid program by capping it permanently, and ending Medicaid expansion as part of its efforts to repeal the Affordable Care Act.

Coverage for substance abuse treatment is how an individual in society has a fighting chance to kick the opioids epidemic for good.

The opioid epidemic is not letting up, and neither can our efforts to fight it.

Congress should include funding for the agency if it asks the agency to take on new matters.

History, including very recent history, has shown that NHTSA is most likely to take action when Congress tells it to do so.

I would be frightened to death if I got into one of these cars and just went off on my own.

I have heard concerns that this legislation as written would prevent States from regulating autonomous vehicle safety without a guarantee that NHTSA would step in.

The President's Budget Estimates submitted to Congress this spring shows NHTSA focusing on deregulatory actions that are in direct conflict with what Congress required it to do.

We should not be moving bills out of committee before we hear from the administration about how the bills would, or could, be implemented.